← Open Payments lookup

ADAM BLAKEMAN: Open Payments

NPI 1275071128 · RIGBY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$661 in 37 payments from 16 companies in 2025. Trend: 2023 $518 · 2024 $1,006 · 2025 $661

Food & beverage: $661
CompanyPaymentsAmount
ABBVIE INC.11$158
Lilly USA, LLC6$93
Vanda Pharmaceuticals Inc.3$69
Axsome Therapeutics, Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38
Astellas Pharma US Inc1$34
PFIZER INC.2$32
Insulet Corporation1$28
Sumitomo Pharma America, Inc.1$22

Products named: MOUNJARO, VRAYLAR, FANAPT, Auvelity, UBRELVY, CAPLYTA, XIFAXAN, Veozah.

Industry payments across ID — which companies pay providers there.